Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. It operates through the following segments: Consumer, Over the Counter (OTC), Prescription, Hospital, and Other Shared Services. The Consumer segment competes in the Fast-Moving Consumer Goods space. The OTC segment focuses on brands sold predominantly in pharmacy, where the pharmacist plays a role in the product choice. The Prescription segment offers products prescribed by medical practitioners, specialized instruments, and surgical products. The Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other Shared Services segment refers to other support services, including the regulatory services in India, as well as the investment in the Indian joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa. The company was founded in 1890 and is headquartered in Midrand, South Africa.
